These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 25203092

  • 1. Idiopathic intracranial hypertension--reply.
    Wall M, McDermott M, Kupersmith M.
    JAMA; 2014 Sep 10; 312(10):1060. PubMed ID: 25203092
    [No Abstract] [Full Text] [Related]

  • 2. Idiopathic intracranial hypertension.
    Sinclair AJ, Woolley R, Mollan SP.
    JAMA; 2014 Sep 10; 312(10):1059-60. PubMed ID: 25203090
    [No Abstract] [Full Text] [Related]

  • 3. Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial.
    Horton JC.
    JAMA; 2014 Sep 10; 311(16):1618-9. PubMed ID: 24756510
    [No Abstract] [Full Text] [Related]

  • 4. The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait.
    Beck RW.
    J Neuroophthalmol; 2016 Mar 10; 36(1):1-3. PubMed ID: 26882233
    [No Abstract] [Full Text] [Related]

  • 5. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
    NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ.
    JAMA; 2016 Mar 10; 311(16):1641-51. PubMed ID: 24756514
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
    ten Hove MW, Friedman DI, Patel AD, Irrcher I, Wall M, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group.
    J Neuroophthalmol; 2016 Mar 10; 36(1):13-9. PubMed ID: 26587993
    [Abstract] [Full Text] [Related]

  • 8. Fulminant idiopathic intracranial hypertension managed with oral acetazolamide.
    Espino Barros Palau A, Morgan ML, Yalamanchili S, Lee AG.
    Can J Ophthalmol; 2016 Aug 10; 51(4):e121-e125. PubMed ID: 27521679
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.
    Cello KE, Keltner JL, Johnson CA, Wall M, NORDIC Idiopathic Intracranial Hypertension Study Group.
    J Neuroophthalmol; 2016 Mar 10; 36(1):6-12. PubMed ID: 26618282
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Young Woman With Headaches and Blurry Vision.
    Scott NL, Stryjewski TP, Rizzo JF.
    JAMA Ophthalmol; 2017 Jun 01; 135(6):663-664. PubMed ID: 28301650
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Familial idiopathic intracranial hypertension: two paediatric case reports].
    Rodà D, Fons-Estupiña MC, Vidal-Santacana M.
    Rev Neurol; 2014 Jul 16; 59(2):93-6. PubMed ID: 25005323
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Idiopathic intracranial hypertension in a young child without visual symptoms or signs.
    Winner P, Bello L.
    Headache; 1996 Oct 16; 36(9):574-6. PubMed ID: 8916568
    [Abstract] [Full Text] [Related]

  • 19. An 18-year-old woman with unexplained vision loss.
    Leonen KE.
    J Emerg Nurs; 2002 Apr 16; 28(2):179-80. PubMed ID: 11960137
    [No Abstract] [Full Text] [Related]

  • 20. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.
    Smith SV, Friedman DI.
    Headache; 2017 Sep 16; 57(8):1303-1310. PubMed ID: 28758206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.